Sun Pharma shares are in focus as the company has a specialty portfolio, which is 19% of its sales. As per analysts, the read through for Sun Pharma is positive.
Sun Pharma shares are in focus as the company has a specialty portfolio, which is 19% of its sales. As per analysts, the read through for Sun Pharma is positive.